• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病病程中水痘感染的管理

Management of varicella infection during the course of inflammatory bowel disease.

作者信息

Mouzas I A, Greenstein A J, Giannadaki E, Balasubramanian S, Manousos O N, Sachar D B

机构信息

Department of Gastroenterology, University Hospital, Heraklion, Greece.

出版信息

Am J Gastroenterol. 1997 Sep;92(9):1534-7.

PMID:9317080
Abstract

OBJECTIVE

To study the natural history and outcome of varicella infection developing in steroid treated inflammatory bowel disease.

BACKGROUND

Varicella infection occurring in immunosuppressed or immunocompromised patients is a common problem with a significant mortality. Varicella infection during the course of inflammatory bowel disease has been reported in a small number of patients with at least one fatality.

METHODS

Four young patients with inflammatory bowel disease who developed varicella infection while on immunosuppressive therapy, steroids, or azathioprine were studied. In each patient the infection was severe, and the three most recently treated patients received acyclovir.

RESULTS

All four patients developed severe varicella infection while receiving immunosuppressive therapy for their disease. Three patients were treated with intravenous acyclovir with concomitant reduction of steroid dosage and recovered completely. One patient, treated in 1980 with antibiotics and reduction in steroids, did not receive acyclovir and also survived.

CONCLUSIONS

Varicella infection is a relatively uncommon occurrence in inflammatory bowel disease. If varicella infection occurs, prompt diagnosis and treatment with acyclovir and concomitant reduction in immunosuppressive therapy (reduction in steroid dosage and discontinuation of azathioprine) should be initiated immediately to limit viremia and avoid fatal complications.

摘要

目的

研究在接受类固醇治疗的炎症性肠病患者中发生的水痘感染的自然病史及转归。

背景

免疫抑制或免疫功能低下患者发生的水痘感染是一个常见问题,死亡率较高。少数炎症性肠病患者在病程中发生了水痘感染,至少有1例死亡报告。

方法

对4例在接受免疫抑制治疗、类固醇或硫唑嘌呤治疗期间发生水痘感染的年轻炎症性肠病患者进行了研究。每例患者的感染都很严重,最近3例接受治疗的患者使用了阿昔洛韦。

结果

所有4例患者在接受疾病免疫抑制治疗期间均发生了严重的水痘感染。3例患者接受了静脉注射阿昔洛韦治疗,同时减少了类固醇剂量,最终完全康复。1例于1980年接受抗生素治疗并减少类固醇剂量的患者未使用阿昔洛韦,也存活了下来。

结论

水痘感染在炎症性肠病中相对少见。如果发生水痘感染,应立即进行快速诊断,使用阿昔洛韦治疗,并同时减少免疫抑制治疗(减少类固醇剂量并停用硫唑嘌呤),以限制病毒血症并避免致命并发症。

相似文献

1
Management of varicella infection during the course of inflammatory bowel disease.炎症性肠病病程中水痘感染的管理
Am J Gastroenterol. 1997 Sep;92(9):1534-7.
2
Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.近期的类固醇疗法会加重急性淋巴细胞白血病患儿水痘感染的严重程度。
Pediatrics. 2005 Oct;116(4):e525-9. doi: 10.1542/peds.2005-0219.
3
Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.
Am J Gastroenterol. 1999 Feb;94(2):424-6. doi: 10.1111/j.1572-0241.1999.871_w.x.
4
[Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease].[在使用硫唑嘌呤治疗克罗恩病过程中发生的严重水痘带状疱疹肺炎]
Rev Mal Respir. 2003 Nov;20(5 Pt 1):773-6.
5
Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.预测炎症性肠病患儿初诊时对硫唑嘌呤的需求。
J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):123-9. doi: 10.1097/MPG.0b013e318156a834.
6
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.他克莫司对重度激素难治性或激素依赖性炎症性肠病患者安全有效——一项长期随访研究
Am J Gastroenterol. 2006 May;101(5):1048-56. doi: 10.1111/j.1572-0241.2006.00524.x.
7
Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus.一名免疫功能低下的成年人发生致命性水痘,与水痘带状疱疹病毒的欧洲基因型E2变异株有关。
J Clin Virol. 2009 Jan;44(1):70-3. doi: 10.1016/j.jcv.2008.10.004. Epub 2008 Dec 3.
8
Cytomegalovirus infection in patients with inflammatory bowel disease.炎症性肠病患者的巨细胞病毒感染
Am J Gastroenterol. 1999 Apr;94(4):1053-6. doi: 10.1111/j.1572-0241.1999.01013.x.
9
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.通过RAND方法评估炎症性肠病中免疫抑制药物的适用性:意大利炎症性肠病研究小组(IG-IBD)立场声明
Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013.
10
6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.接受硫唑嘌呤治疗的炎症性肠病类固醇依赖患者的6-硫鸟嘌呤监测
Aliment Pharmacol Ther. 2005 Apr 1;21(7):829-39. doi: 10.1111/j.1365-2036.2005.02419.x.

引用本文的文献

1
Immunisation status of children and adolescents with a new diagnosis of inflammatory bowel disease.儿童和青少年炎症性肠病新诊断患者的免疫接种状况。
BMC Infect Dis. 2022 Jan 4;22(1):6. doi: 10.1186/s12879-021-06976-x.
2
Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.水痘带状疱疹性脑膜炎并发克罗恩病的肿瘤坏死因子和皮质类固醇联合治疗。
World J Gastroenterol. 2013 Jun 7;19(21):3347-51. doi: 10.3748/wjg.v19.i21.3347.
3
Vaccines and recommendations for their use in inflammatory bowel disease.
疫苗及其在炎症性肠病中的应用建议。
World J Gastroenterol. 2013 Mar 7;19(9):1354-8. doi: 10.3748/wjg.v19.i9.1354.